Clinical trial
A 2-Part, Randomized, Double-Blind, Safety and Tolerability Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00647296 is registered in ClinicalTrials.gov with Knopp Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 2-Part, Randomized, Double-Blind, Safety and Tolerability Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Knopp Biosciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 9, 2008
- Completion date
- September 4, 2009
- Enrollment
- 194 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.